Reference entry
Gonadorelin (GnRH)
Gonadotropin-Releasing Hormone · GnRH Agonist
Overview
Gonadorelin is a synthetic form of the naturally occurring gonadotropin-releasing hormone (GnRH). It stimulates the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which in turn regulate testosterone production in men and ovulation in women. It is FDA-approved for diagnostic testing and fertility treatment. The pulsatile nature of GnRH secretion is critical for proper reproductive function.
Gonadorelin acts as an agonist of the GnRH receptor in the anterior pituitary. When administered in pulses (mimicking natural secretion patterns every 60-120 minutes), it stimulates release of FSH and LH. LH then stimulates Leydig cells in the testes to produce testosterone, or triggers ovulation in women. Continuous exposure paradoxically causes receptor downregulation and suppressed hormone production.
Treatment of conditions like Kallmann syndrome where GnRH deficiency causes low testosterone and infertility.
Induces ovulation in women with hypothalamic amenorrhea who don't ovulate regularly.
Stimulates testosterone and sperm production by restoring LH/FSH pulsatility.
Treatment of delayed puberty due to hypothalamic-pituitary dysfunction.
Mechanism
Gonadorelin is a synthetic form of the naturally occurring gonadotropin-releasing hormone (GnRH). It stimulates the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which in turn regulate testosterone production in men and ovulation in women. It is FDA-approved for diagnostic testing and fertility treatment. The pulsatile nature of GnRH secretion is critical for proper reproductive function.
Gonadorelin acts as an agonist of the GnRH receptor in the anterior pituitary. When administered in pulses (mimicking natural secretion patterns every 60-120 minutes), it stimulates release of FSH and LH. LH then stimulates Leydig cells in the testes to produce testosterone, or triggers ovulation in women. Continuous exposure paradoxically causes receptor downregulation and suppressed hormone production.
Treatment of conditions like Kallmann syndrome where GnRH deficiency causes low testosterone and infertility.
Research areas
- Gonadorelin is a synthetic form of the naturally occurring gonadotropin-releasing hormone (GnRH). It stimulates the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which in turn regulate testosterone production in men and ovulation in women. It is FDA-approved for diagnostic testing and fertility treatment. The pulsatile nature of GnRH secretion is critical for proper reproductive function.
- Gonadorelin acts as an agonist of the GnRH receptor in the anterior pituitary. When administered in pulses (mimicking natural secretion patterns every 60-120 minutes), it stimulates release of FSH and LH. LH then stimulates Leydig cells in the testes to produce testosterone, or triggers ovulation in women. Continuous exposure paradoxically causes receptor downregulation and suppressed hormone production.
- Treatment of conditions like Kallmann syndrome where GnRH deficiency causes low testosterone and infertility.
- Induces ovulation in women with hypothalamic amenorrhea who don't ovulate regularly.
- Stimulates testosterone and sperm production by restoring LH/FSH pulsatility.
- Treatment of delayed puberty due to hypothalamic-pituitary dysfunction.
- Used to assess hypothalamic-pituitary function and diagnose GnRH deficiency.
- Evaluates pituitary reserve and responsiveness to GnRH stimulation.
- Maintains testicular function and fertility during testosterone replacement therapy.
- Helps restore natural testosterone production after anabolic steroid use.
- Treatment of undescended testes in pediatric patients.
Research notes
- Injection site reactions
- Headache
- Flushing
- Abdominal discomfort
- Signs of allergic reaction (rash, difficulty breathing)
- Severe headaches
- Unusual abdominal pain
- Hormone-sensitive tumors
- Pregnancy
- Hypersensitivity to GnRH or analogs
- Conditions worsened by sex hormone release
Pharmacokinetics
- Gonadorelin acts as an agonist of the GnRH receptor in the anterior pituitary. When administered in pulses (mimicking natural secretion patterns every 60-120 minutes), it stimulates release of FSH and LH. LH then stimulates Leydig cells in the testes to produce testosterone, or triggers ovulation in women. Continuous exposure paradoxically causes receptor downregulation and suppressed hormone production.
FAQs
Why is pulsatile Gonadorelin dosing critical, and what happens with continuous dosing?
Gonadorelin must be dosed in pulses (every 90-120 minutes) to mimic natural GnRH secretion patterns. Continuous exposure paradoxically causes GnRH receptor desensitization and downregulation, suppressing LH and FSH release—the opposite of desired effects. Proper pulsatile timing is essential for therapeutic success.
Is Gonadorelin better than hCG for maintaining testicular function during TRT?
Both Gonadorelin and hCG maintain testicular function and fertility during TRT, but they work differently. hCG directly mimics LH with a 24-36 hour half-life, while Gonadorelin stimulates natural LH/FSH release but requires pulsatile dosing. hCG is simpler to administer; Gonadorelin offers more physiological restoration of the HPG axis.
How quickly does Gonadorelin raise testosterone after injection?
Gonadorelin has an extremely short 2-4 minute half-life, triggering LH release within minutes. Testosterone elevation from LH stimulation begins within hours, with peak levels at 6-12 hours post-injection. This rapid response makes it suitable for diagnostic testing and pulsatile protocols.
Can Gonadorelin be used long-term for post-cycle therapy, or just short-term?
Gonadorelin is effective for both acute (diagnostic) use and extended post-cycle protocols lasting 2-3 weeks. However, its extreme sensitivity to dosing frequency makes it less practical long-term than hCG or clomiphene. Most PCT protocols use Gonadorelin initially then transition to other agents for maintenance.